AFM24 is a tetravalent bispecific antibody in which the anti-EGFR scFv is fused to the c-terminus of the anti-CD16a antibody via a connector, which mediates the killing of tumor cells by NK cells in an EGFR-dependent manner (195). Here, EGFR is linked to neoplasm.